FDA Inspection 1280181 — Navaneeth Ashokkumar, MD
The FDA completed an inspection of Navaneeth Ashokkumar, MD on Aug 9, 2025 in Manipal. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 9, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Manipal (India)
Additional Details
Clinical BA/BE